Viewing Study NCT00692250


Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2026-01-04 @ 5:30 AM
Study NCT ID: NCT00692250
Status: COMPLETED
Last Update Posted: 2015-05-05
First Post: 2008-06-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess Any Potential Interaction Between Colesevelam and Ciclosporin in Healthy Volunteers
Sponsor: Genzyme, a Sanofi Company
Organization:

Study Overview

Official Title: A Phase I Open Label, Randomised, Single Dose, 2-way Crossover, 2-Sequence Pharmacokinetic Study on the Interaction of Colesevelam and Ciclosporin in Healthy Volunteers
Status: COMPLETED
Status Verified Date: 2015-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is designed to assess any potential interaction between colesevelam and ciclosporin in healthy volunteers.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
EudraCT 2007-003724-38 None None View